AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Aug 12, 2021
30016_dirs_2021-08-12_a3e51841-9f06-4fd1-95dc-3da9a6ef1d46.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-08-10
Reporting Person: JUNIUS DANIEL M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock | M | 2402 | $85 | Acquired | 5298 | Direct |
| 2021-08-10 | Common Stock | S | 2402 | $679.5818 | Disposed | 2896 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Non-Qualified Stock Option (right-to-buy) | $85 | M | 2402 | Disposed | 2026-05-03 | Common Stock (2402) | Direct |
Footnotes
F1: Represents the weighted average price of the shares sold ranging from a low of $679.47 to a high of $680.09 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the date of the 2017 annual meeting of shareholders.
F3: Not applicable.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13